Spire Healthcare Group plc (LON:SPI - Get Free Report)'s share price was down 22.1% on Thursday . The company traded as low as GBX 174.60 ($2.25) and last traded at GBX 174.80 ($2.25). Approximately 1,500,525 shares were traded during trading, an increase of 157% from the average daily volume of 584,388 shares. The stock had previously closed at GBX 224.50 ($2.89).
The stock has a market cap of £754.95 million, a PE ratio of 26.76, a price-to-earnings-growth ratio of 1.06 and a beta of 0.96. The stock has a 50-day moving average price of GBX 229.09 and a two-hundred day moving average price of GBX 230.72. The company has a debt-to-equity ratio of 62.25, a current ratio of 0.70 and a quick ratio of 0.74.
Spire Healthcare Group plc, together with its subsidiaries, owns and operates private hospitals and clinics. It offers various treatments in the areas of allergy and infectious diseases, blood tests, bones and joints, bowel treatments, breast screening and surgery, cancer investigations and treatments, cosmetic surgery, cyst removal, and dental surgery, as well as ear, nose, and throat treatments.
This instant news alert was generated by narrative science technology and financial data from MarketBeat in order to provide readers with the fastest and most accurate reporting. This story was reviewed by MarketBeat's editorial team prior to publication. Please send any questions or comments about this story to contact@marketbeat.com.
Before you consider Spire Healthcare Group, you'll want to hear this.
MarketBeat keeps track of Wall Street's top-rated and best performing research analysts and the stocks they recommend to their clients on a daily basis. MarketBeat has identified the five stocks that top analysts are quietly whispering to their clients to buy now before the broader market catches on... and Spire Healthcare Group wasn't on the list.
While Spire Healthcare Group currently has a Buy rating among analysts, top-rated analysts believe these five stocks are better buys.